請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/27662
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 彭福佐(Fu-Chuo Peng) | |
dc.contributor.author | Pao-Sung Li | en |
dc.contributor.author | 李寶松 | zh_TW |
dc.date.accessioned | 2021-06-12T18:14:25Z | - |
dc.date.available | 2012-09-13 | |
dc.date.copyright | 2007-09-13 | |
dc.date.issued | 2007 | |
dc.date.submitted | 2007-08-30 | |
dc.identifier.citation | Addison, and W. R., Kurtz, D. T. (1989) Identification of nuclear proteins that bind to the glucocorticoid regulatory region of a rat alpha 2u-globulin gene. J. Biol. Chem. 264: 21891-21895.
Alvares, and A. P., Mannering, G. J. (1970) Two-substrate kinetics of drug-metabolizing enzyme systems of hepatic microsomes. Mol. Pharmacol. 6: 206-212. Bandiera, S., and Dworschak, C. (1992) Effects of testosterone and estrogen on hepatic levels of cytochromes P450 2C7 and P450 2C11 in the rat. Arch. Biochem. Biophys.; 296: 286-295. Barwick, J. L., Quattrochi, L. C., Mills, A. S., Potenza, C., Tukey, R. H., Guzelian P. S. (1996) Trans-species gene transfer for analysis of glucocorticoid-inducible transcriptional activation of transiently expressed human CYP3A4 and rabbit CYP3A6 in primary cultures of adult rat and rabbit hepatocytes. Mol. Pharmacol.; 50: 10-16 Berrodin, T. J., Marks, M. S., Ozato, K., Linney, E., and Lazar, M. A. (1992) Heterodimerization among thyroid hormone receptor, retinoic acid receptor, retinoid X receptor, chicken ovalbumin upstream promoter transcription factor, and an endogenous liver protein. Mol .Endocrinol. 6: 1468-1478. Blumberg, B., and Evans, R. M. (1998) Orphan nuclear receptors--new ligands and new possibilities. Genes. Dev. 12: 3149-3155. Burger, H. J., Schuetz, J. D., Schuetz, E. G., and Guzelian, P. S. (1992) Paradoxical transcriptional activation of rat liver cytochrome P-450 3A1 by dexamethasone and the antiglucocorticoid pregnenolone 16 alpha-carbonitrile: analysis by transient transfection into primary monolayer cultures of adult rat hepatocytes. Proc. Nat.l Acad. Sci. U S A 89: 2145-2149. Burnstein K. L., Maiorino, C. A., Dai, J. L., Cameron, D. J. (1995) Androgen and glucocorticoid regulation of androgen receptor cDNA expression. Mol. Cell. Endocrinol. 115: 177-186. Ding, X., and Staudinger, J. L. (2005) Repression of PXR-mediated induction of hepatic CYP3A gene expression by protein kinase C. Biochem. Pharmacol. 69: 867-873 Dogra, S. C., Whitelaw, M. L., and May, B. K. (1998) Transcriptional activation of cytochrome P450 genes by different classes of chemical inducers. Clin. Exp. Pharmacol. Physiol. 25: 1-9. Elshourbagy, N. A., and Guzelian, P. S. (1980) Separation, purification, and characterization of a novel form of hepatic cytochrome P-450 from rats treated with pregnenolone-16 alpha-carbonitrile. J. Biol. Chem. 255: 1279-1285. Eriko Mikamo., Shingo Harada., Jun-ichi Nishikawa. (2003) Tsutomu Nishihara. Methoxychlor Induces CYP2C11 to Convert Itself into Hormonally Active Metabolites. Health. Sci. 3: 229-232 Garfinkel, D. (1998) Studies on pig liver microsomes. I. Enzymatic and pigment composition of different microsomal preparations. Arch. Biochem. Biophys. 77: 367-381 Ghosal, A., Sadrieh, N., Reik, L., Levin, W., and Thomas, P. E. (1996) Induction of the male-specific cytochrome P450 3A2 in female rats by phenytoin. Arch. Biochem. Biophys. 332: 153-162. Gonzalez, F. J., Song, B. J., and Hardwick, J. P. (1986) Pregnenolone 16 alpha-carbonitrile-inducible P-450 gene family: gene conversion and differential regulation. Mol. Cell. Biol. 6: 2969-2976. Gonzalez, F. J. (1989) The molecular biology of cytochrome P450s. Pharmacol. Rev. 40: 243-288 Goodwin, B., Hodgson, E., and Liddle, C. (1999) The orphan human pregnane X receptor mediates the transcriptional activation of CYP3A4 by rifampicin through a distal enhancer module. Mol. Pharmacol. 56: 1329-1339. Goodwin, B., Redinbo, M. R., and Kliewer, S. A. (2002) Regulation of cyp3a gene transcription by the pregnane x receptor. Annu. Rev. Pharmacol. Toxicol. 42: 1-23. Guzelian, P. S. (1988) Regulation of the glucocorticoid-inducible cytochromes P-450. Microsomes and drug oxidations. 1988; 148-155 Hall, R. E., Tilley W. D., McPhaul, M. J., and Sutherland R. L. (1992) Regulation of androgen receptor gene expression by steroids and retinoic acid in human breast-cancer cells. Int. J. cancer. 52: 778-784 Heuman, D. M., Gallagher, E. J., Barwick J. L., Elshourbagy, N. A., and Guzelian, P. S. (1982) Immunochemical evidence for induction of a common form of hepatic cytochrome P-450 in rats treated with pregnenolone-16 alpha-carbonitrile or other steroidal or non-steroidal agents. Mol .Pharmacol. 21: 753-760. Holck, H. G. O., Munir, A. K., Mills, L. M., and Smith, E. L. (1973) Studies upon the sex-difference in rats in tolerance to certain barbiturates and to nicotine. J. Pharmacol. Exp. Therap. 60: 323 Huss, J. M., and Kasper, C. B. (1998) Nuclear receptor involvement in the regulation of rat cytochrome P450 3A23 expression. J. Biol. Chem. 273: 16155-16162 Huss, J. M., and Kasper, C. B. (2000) Two-stage glucocorticoid induction of CYP3A23 through both the glucocorticoid and pregnane X receptors. Mol. Pharmacol. 58: 48-57. Huss, J. M., Wang, S. I., Astrom, A., McQuiddy, P., and Kasper, C.B. (1996) Dexamethasone responsiveness of a major glucocorticoid-inducible CYP3A gene is mediated by elements unrelated to a glucocorticoid receptor binding motif. Proc. Natl. Acad. Sci. U S A 93: 4666-4670. Ishii, T., Nishimura, K., and Nishimura, M. (2006) Administration of xenobiotics with anti-estrogenic effects results in mRNA induction of adult male-specific cytochrome P450 isozymes in the livers of adult female rats. J .Pharmacol. Sci. 101: 250-255. Jansson, J. O., Eden, S., and Isaksson, O. (1985) Sexual dimorphism in the control of growth hormone secretion. Endocr. Rev. 6: 128-150. Kamataki, T., Maeda, K., Yamazoe Y., Nagai, T., and Kato, R. (1983) Sex difference of cytochrome P-450 in the rat: purification, characterization, and quantitation of constitutive forms of cytochrome P-450 from liver microsomes of male and female rats. Arch. Biochem. Biophys. 225: 758-770. Kato, R. (1974) Sex-related differences in drug metabolism. Drug. Metab. Rev. 3: 1-32. Kato, R., and Kamataki, T. (1982) Cytochrome P-450 as a determinant of sex difference of drug metabolism in the rat. Xenobiotica 12: 787-800. Kato, R., and Yamazoe, Y. (1992) Sex-specific cytochrome P450 as a cause of sex- and species-related differences in drug toxicity. Toxicol. Lett. 64-65 Spec : 661-667. Kariya, S., Isozaki, S., Narimatsu, S., Suzuki, T. (1992) Oxidative metabolism of cinnarizine in rat liver microsomes. Biochem. Pharmacol. 44: 1471-1474. Klein, E. S., DiLorenzo, D., Posseckert, G., Beato, M., and Ringold, G. M. (1988) Sequences downstream of the glucocorticoid regulatory element mediate cycloheximide inhibition of steroid induced expression from the rat alpha 1-acid glycoprotein promoter: evidence for a labile transcription factor. Mol. Endocrinol. 2: 1343-1351. Kliewer, S. A., Moore, J. T., Wade, L., Staudinger, J. L., Watson, M. A., Jones, S. A., McKee D. D., Oliver, B. B., Willson, T. M., Zetterström, R.H., Perlmann, T., and Lehmann, J. M. (1998) An orphan nuclear receptor activated by pregnanes defines a novel steroid signaling pathway. Cell. 92 :73-82. Klingenberg, M. (1958) Pigments of rat liver microsomes. Arch. Biochem. Biophys. 75: 376-386. Laemmli, U. K., Beguin, F., and Gujer-Kellenberger G. (1970) A factor preventing the major head protein of bacteriophage T4 from random aggregation. J. Mol. Biol. 47: 69-85. Legraverend, C., Mode, A., Westin S., Strom, A., Eguchi, H., Zaphiropoulos, P. G., and Gustafsson, J. A. (1992) Transcriptional regulation of rat P-450 2C gene subfamily members by the sexually dimorphic pattern of growth hormone secretion. Mol. Endocrinol. 6: 259-266. Mugford, C. A., and Kedderis, G. L. (1998) Sex-dependent metabolism of xenobiotics. Drug. Metab. Rev. 30: 441-498. Pampori, N. A., and Shapiro, B. H. (1999) Gender differences in the responsiveness of the sex-dependent isoforms of hepatic P450 to the feminine plasma growth hormone profile. Endocrinology 140: 1245-1254. Peng, F. C., Wu, S. W., and Lin, J. L. (2001a) Metabolism of territrem a in liver microsomes from wistar rats: 2. Sex differences and regulation with gonadal hormones and phenobarbital. J. Toxicol. Environ. Health. 64: 661-671. Poter, T. D., and Coon, M. J. (1991) Cytochrome P-450. Multiplicity of isoforms, substrates, and catalytic and regulatory mechanisms. J. Biol. Chem. 266: 13469-13472 Schuetz, E. G., and Guzelian, P. S. (1984) Induction of cytochrome P-450 by glucocorticoids in rat liver. II. Evidence that glucocorticoids regulate induction of cytochrome P-450 by a nonclassical receptor mechanism. J. Biol. Chem. 259: 2007-2012. Shimada, M., Nagata, K., Murayama, N., Yamazoe, Y., Kato, R. (1989) Role of growth hormone in modulating the constitutive and phenobarbital-induced levels of two P-450(6)beta (testosterone 6 beta-hydroxylase) mRNAs in rat livers. J. Biochem. 106: 1030-1034. Suzuki, K., Ito, K., Kurokawa, K., Suzuki, T., Shimizu, N., Fukabori, Y., Honma, S., and Yamanaka, H. (1997) Expression and degradation of rat androgen receptor following castration, testosterone replacement and antiandrogens administration: analysis by Western blot and immunohistochemistry. Tohoku. J. Exp. Med.183: 159-172 Vamvakopoulos, N. C., Mayol, V., Margioris, A. N., and Chrousos, G. P. (1992) Lack of dexamethasone modulation of mRNAs involved in the glucocorticoid signal transduction pathway in two cell systems. Steroids 57: 282-287. Watkins, R. E., Wisely, G. B., Moore, L. B., Collins, J. L., Lambert, M. H., Williams, S. P., Willson, T. M., Kliewer, S. A., Redinbo, M. R. (2001) The human nuclear xenobiotic receptor PXR: structural determinants of directed promiscuity. Science. 292: 2329-2333 Waxman, D. J., Pampori, N. A., Ram, P. A., Agrawal, A. K., and Shapiro, B. H. (1991) Interpulse interval in circulating growth hormone patterns regulates sexually dimorphic expression of hepatic cytochrome P450. Proc. Natl. Acad. Sci. U S A 88: 6868-6872. Wilkinson, G. R. (1996) Cytochrome P4503A (CYP3A) metabolism: prediction of in vivo activity in humans. J. Pharmacokinet. Biopharm. 24: 475-490. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/27662 | - |
dc.description.abstract | 細胞色素P450超級家族為重要Phase I代謝酵素,其中細胞色素次家族3A參與許多外來物質及藥物的代謝且可被許多廣泛的物質所誘導。大鼠肝臟中主要的細胞色素P450 3A次家族為CYP3A1與CYP3A2,CYP3A1可被dexamethasone強烈誘導表現但是CYP3A2只能被微弱地誘導。許多報導指出dexamethasone誘導CYP3A表現應該不是經由傳統的glucocorticoid receptor路徑,反而是一些孤兒受體(orphan nuclear receptor)來參與。最近認為PXR (Pregnane X receptor)應為誘導CYP3A重要的調控因子,PXR與其ligand結合進入核中與CYP3A的promoter結合而活化此基因的轉錄活性。
CYP3A2為雄性特異性的酵素,在成熟雄性大鼠中表現而雌性大鼠則幾乎不表現,此性別差異性是由於雄性荷爾蒙可誘導調控CYP3A2表現,有許多報導指出雄性荷爾蒙透過調控生長荷爾蒙分泌的間接機制來調控CYP3A2,但其詳細的分子機制仍不十分清楚。 為了探討CYP3A的誘導作用主要由哪些核受體參與,本實驗室給予大鼠dexamethasone腹腔注射偵測肝臟微粒體中各種核受體蛋白表現。在in vitro實驗大鼠肝癌細胞培養給予dexamethasone後偵測各種核受體蛋白表現。為了探討雄性荷爾蒙是否經過androgen receptor調控CYP3A2表現,雄性大鼠經性腺切除再給予雄性荷爾蒙及androgen receptor拮抗劑flutamide觀察其是否對雄性荷爾蒙調控CYP3A2造成影響。為了探討雄性荷爾蒙是經由間接或直接的方式調控CYP3A2,以大鼠肝癌細胞處理DHT偵測CYP3A2在體外表現情形。 結果顯示: (1).Dxamethasone調控CYP3A1表現中PXR、與HNF-4α等核受體應佔重要角色,而核受體COUP-TF1並明顯表現變化。 (2)在動物實驗及細胞實驗中皆可發現dexamethasone對AR蛋白表現有強烈抑制的現象,有報導指出dexamethasone或許是透過GR影響AR的基因表現。 (3)細胞處理DHT並無法誘導CYP3A2的表現,因此雄性荷爾蒙調控CYP3A2應該是經由間接的機制來執行。 | zh_TW |
dc.description.abstract | Cytochrome P450s are important Phase I enzymes. CYP3A subfamily enzymes are involved in metabolism of many xenobiotics and drugs and induced by substances of large structural diversity. In rat liver, CYP3A1 and CYP3A2 are major CYP3A enzymes. The former is induced intensely by dexamethasone but the latter is just induced slightly. It was reported that induction of CYP3A by dexamethasone is not through classical glucocorticoid receptor pathway but some orphan nuclear receptors. Recently it was regarded that pregnane X receptor (PXR) should play an important role in CYP3A induction. PXR binds to its ligand and then enter nucleus to interact with CYP3A gene promoter to activate transcription.
CYP3A2 is belong to the male specicic enzyme, so it expresses in adult male rat liver but hardly in adult rat liver. The sexual dimorphism is due to involvement of androgen in regulating CYP3A2 expression. It was reported that androgen regulate CYP3A2 expression by influencing growth hormone secretion profiles but the molecular mechanism is not yet so clear. To explore which nuclear receptors are involved in CYP3A induction, rats were treated dexamethasone and the nuclear receptors were detected. To explore whether androgen receptor is involved in CYP3A2 regulation by testosterone, castrated male rats were treated tesetosterone and androgen receptor antagonist flutamide and CYP3A2 expression was detected. To explore whether testosterone regulate CYP3A2 directly, cultured rat hepatoma cells were treated DHT and CYP3A2 expression was detected. The results indicated: (1)nuclear receptors such as PXR and HNF-4α should play an important role in CYP3A induction by dexamethasone. (2)In vitro and in vivo study indicated that AR protein had strongly down-regulation effect by dexamethasone. It was reported that dexamethasone could interact with AR gene through GR. (3)In vitro cell culture study indicated DHT did not have induction effects on CYP3A2 expression and it is suggested that CYP3A2 expression regulation by androgen should be direct mechanism. | en |
dc.description.provenance | Made available in DSpace on 2021-06-12T18:14:25Z (GMT). No. of bitstreams: 1 ntu-96-R93447010-1.pdf: 4381212 bytes, checksum: 09ad56a712043172c0e4838570bcd5d0 (MD5) Previous issue date: 2007 | en |
dc.description.tableofcontents | 誌謝 i
中文摘要 ii 英文摘要 iv 圖目錄 .ix 表目錄 xiii 縮寫表 xiv 第一章 緒論………………………………………………………………………..…1 1.1前言…………………………………………………………………………..1 1.2細胞色素P450 (Cytochrome P450)超級家族……………………………….1 1.2.1細胞色素P450 3A次家族……………………………………………...…2 1.2.2細胞色素P450的誘導與上游基因調控機制…………………………..…3 1.2.3細胞色素P450性別差異性………………………………………….……4 1.2.4細胞色素P450參與土震素代謝及性別上的差異…………………….…5 1.2.5細胞色素P450 3A之誘導…………………………………………………6 1.2.6雄性荷爾蒙與細胞色素P450 3A之關聯性………………………………7 1.3核受體超級家族(Nuclear receptor superfamily)………………….…………8 1.3.1 Pregnane X receptor (PXR)………………………………………...………9 1.3.2 RXR (9-cis-retionic acid receptor)……………………………..…………11 1.3.3 HNF-4及COUP-TF核受體………………………………..……………11 1.4研究動機與目的……………………………………………………...…….12 第二章 實驗材料與方法………………………………………………………...….14 2.1實驗藥品………………………………………………………….….……..14 2.2實驗器材………………………………………………………….….……..14 2.3實驗動物………………………………………………………..….……….15 2.4.1雄性大鼠睪丸切除手術………………………………………...………..15 2.4.2性腺未切除雄性大鼠之處理…………………………………………….16 2.4.3性腺切除雄性大鼠之處理………………………………………….……16 2.4.4性腺切除雄性大鼠給予單次高劑量dexamethasone處理……….……..16 2.4.5性腺切除雄性大鼠給予多次低劑量dexamethasone處理……….……..17 2.4.6性腺切除雄性大鼠給予多次低劑量testosterone處理……………....….17 2.4.7動物組織之收集……………………………………………….…..……..17 2.4.8肝臟微粒體之製備……………………………………………………….17 2.4.9微粒體蛋白含量測定…………………………………………………….18 2.4.10 McA-RH7777細胞培養…………………………………………...……18 2.4.11聚丙烯醯胺膠電泳(Sodium dodecyl sulfatepolyacrylamide gel electrophoresis, SDS-PAGE)及免疫墨染(Immunoblot)分析………..….19 2.5統計與分析…………………………………………………………..……..20 第三章 實驗結果………………………………………………………..…….…….21 3.1動物生長曲線及肝重紀錄………………………………..………………..21 3.2處理dexamethasone雄性大鼠肝臟微粒體中CYP3A1蛋白的表現……21 3.3 McA-RH7777細胞株處理dexamethasone後各時間點 CYP3A1蛋白表現.........................................................................................22 3.4處理dexamethasone雄性大鼠肝臟微粒體中PXR蛋白的表現..................22 3.5處理dexamethasone雄性大鼠肝臟微粒體中HNF-4α蛋白的表現…..…23 3.6處理dexamethasone雄性大鼠肝臟微粒體中COUP-TF1蛋白的表現..…23 3.7處理dexamethasone雄性大鼠肝臟微粒體中GR蛋白的表現……..……24 3.8 McA-RH7777細胞株處理dexamethasone後各時間點GR蛋白表現……24 3.9處理dexamethasone雄性大鼠肝臟微粒體中CYP3A2蛋白的表現…..…25 3.10 McA-RH7777細胞株處理dexamethasone後各時間點 CYP3A2蛋白表現………………………………………...……………………25 3.11處理dexamethasone雄性大鼠肝臟微粒體中AR蛋白的表現………..…25 3.12 McA-RH7777細胞株處理dexamethasone後各時間點AR蛋白表現..…25 3.13處理testosterone雄性大鼠肝臟微粒體中CYP3A2蛋白的表現…….…..26 3.14 McA-RH7777細胞株處理DHT後各時間點CYP3A2蛋白表現…….…26 3.15處理testosterone雄性大鼠肝臟微粒體中PXR蛋白的表現…………….26 3.16處理testosterone雄性大鼠肝臟微粒體中HNF-4α蛋白的表現……….27 3.17處理testosterone雄性大鼠肝臟微粒體中COUP-TF1蛋白的表現…….27 3.18處理testosterone雄性大鼠肝臟微粒體中AR蛋白的表現……………..27 3.19 McA-RH7777細胞株處理DHT後各時間點AR蛋白表現……………..27 3.20處理testosterone雄性大鼠肝臟微粒體中CYP3A1蛋白的表現………28 283.21 McA-RH7777細胞株處理DHT後各時間點CYP3A1蛋白表現…….28 第四章 實驗討論……………………………………………………………………29 4.1討論…………………………………………………………………………29 4.2總結與未來展望……………………………………………………………37 參考文獻……………………………………………………………………………..39 附圖………………………………………………………………………….……….47 附表…………………………………………………………………….…………….79 | |
dc.language.iso | zh-TW | |
dc.title | 由分子觀點來探討dexamethasone及testosterone調控細胞色素P450 3A1及3A2之機制 | zh_TW |
dc.title | Molecular Aspect of Cytochrome P450 3A1 and 3A2 regulated by Dexamethasone and Testosterone | en |
dc.type | Thesis | |
dc.date.schoolyear | 95-2 | |
dc.description.degree | 碩士 | |
dc.contributor.oralexamcommittee | 林國煌,郭宗禮,曾淑芬 | |
dc.subject.keyword | CYP3A1,CYP3A2,dexamethasone,雄性荷爾蒙,核受體, | zh_TW |
dc.subject.keyword | CYP3A1,CYP3A2,dexamethasone,androgen,nuclear receptor, | en |
dc.relation.page | 85 | |
dc.rights.note | 有償授權 | |
dc.date.accepted | 2007-08-31 | |
dc.contributor.author-college | 醫學院 | zh_TW |
dc.contributor.author-dept | 毒理學研究所 | zh_TW |
顯示於系所單位: | 毒理學研究所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-96-1.pdf 目前未授權公開取用 | 4.28 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。